CVS Health (CVS) closed the most recent trading day at $61.96, moving -2.12% from the previous trading session. This change lagged the S&P 500's 0.01% loss on the day. Elsewhere, the Dow lost 0.32%, ...

CVS Health (NYSE:CVS) shares extended six straight sessions of losses, as the stock slipped 0.7% at $63.38 on Thursday. The ...

For CVS, Q2 earnings will be a critical inflection point. A miss could trigger a breakup or further decline, making the stock ...

This was the stock's eighth consecutive day of losses.

CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.

The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...

The lawsuit was filed under the False Claims Act, which helps the government combat fraud and requires tripling of damages, ...

The most important philosophy we have of AI is that AI will never make decisions. Period. So AI would help us collect the ...

A federal judge ordered CVS Health's Omnicare unit to pay $948.8 million in penalties and damages, in a whistleblower lawsuit ...

CVS Health’s revenue of $89.8 billion in Q3 was up 11% y-o-y, with sales growth across all segments. Looking at segments, Health Care Benefits sales increased by 17%, Health Services sales were ...

CVS Health’s Caremark business signed a new pharmacy benefits contract with the California Public Employees’ Retirement ...